Latest Breaking News On - Nadeemq mirza - Page 1 : comparemela.com

Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients

ATRN-119 is the first and only macrocyclic ATR inhibitor in the clinic, with best in class potential

United statesNadeemq mirzaMike moyerSafety review committeeExchange commissionAprea therapeutics incSecurities exchangeChief medical officerSecurities actSecurities exchange actFinancial condition

Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update

Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoNadeemq mirzaOren giladMike moyerExchange commissionAmerican association of cancer researchAprea therapeutics incSecurities exchangeTherapeutics reports firstChief executive officerBusiness updatesPotential upcoming keyInvestigational new drugAmerican associationCancer research

Aprea Therapeutics Announces Appointment of Nadeem Q Mirza, M D , M P H as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Aprea Therapeutics Announces Appointment of Nadeem Q Mirza, M D , M P H as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesOren giladNadeemq mirzaMike moyerCorporate medical affairs at verastem oncologyUniversity of punjabCompany board of directorsClinical development at salarius pharmaceuticalsUniversity of texas at houstonExchange commissionSecurities exchangeAmerica medical affairs at sanofi oncologyAprea therapeutics incChief medical officerAprea therapeuticsSenior vice president

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diegoOren giladNadeemq mirzaMolly hansbargerMike moyerNadeem mirzaFiona simpkinsDennis riedlTimothy yapTeresa leeCenter evaluationExchange commissionAprea therapeutics incSecurities exchangeMd anderson cancer center

Salarius Pharmaceuticals to Host Virtual Key Opinion Leader

Salarius Pharmaceuticals to Host Virtual Key Opinion Leader
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesDavid arthurJohanna bennettMaureen mcenroeKapiln bhallaSantp chawlaJohnathanr whetstineNadeemq mirzaDavidj arthurTiberend strategic advisors incDivision of cancer medicineSalarius pharmaceuticalsMd anderson cancer centerSalarius pharmaceuticals incProduct development awardDepartment of leukemia